Patricia Eckert
Director of Finance/CFO bij ENZO BIOCHEM, INC.
Vermogen: 24 638 $ op 31-03-2024
Profiel
Patricia Eckert is currently the Chief Financial Officer at Enzo Biochem, Inc. She previously worked as the Accounting Director at Pall Corp.
from 2013 to 2017.
Ms. Eckert completed her undergraduate degree and MBA at Hofstra University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ENZO BIOCHEM, INC.
0.04% | 23-02-2024 | 19 400 ( 0.04% ) | 24 638 $ | 31-03-2024 |
Actieve functies van Patricia Eckert
| Bedrijven | Functie | Begin |
|---|---|---|
| ENZO BIOCHEM, INC. | Director of Finance/CFO | - |
Eerdere bekende functies van Patricia Eckert
| Bedrijven | Functie | Einde |
|---|---|---|
| PALL CORPORATION | Comptroller/Controller/Auditor | 01-08-2017 |
Opleiding van Patricia Eckert
| Hofstra University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ENZO BIOCHEM, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Pall Corp.
 Pall Corp. Medical SpecialtiesHealth Technology Pall Corp. designs, manufactures, and markets filtration and separation equipment. Its products are used to remove solid, liquid, and gaseous contaminants from a variety of liquids and gases. The firm has Life Sciences and Industrial segments. The Life Sciences segment focuses on developing, manufacturing, and selling products to customers in the medical, biopharmaceuticals, and food and beverage markets. The Industrial segment focuses on developing, manufacturing and selling products to customers in the process technologies, aerospace, and microelectronics markets. The company was founded by David B. Pall on July 31, 1946 and is headquartered in Port Washington, NY. | Health Technology |
